[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Editorial Board::
Executive Members::
Instruction to Authors::
Peer Review::
Articles Archive::
Indexing Databases::
Contact Us::
Site Facilities::
::
Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
:: Volume 12, Issue 3 (10-2010) ::
J Gorgan Univ Med Sci 2010, 12(3): 18-23 Back to browse issues page
Effect of antenatal Betamethasone on prevention of respiratory distress syndrome among neonates with gestational age of 35-36 weeks
Mansouri M (MD) * 1, Seyedolshohadaei F (MD)2 , Company F (MD)3 , Setare Sh (MD)4 , Mazhari S (BSc)5
1- Assistant Professor, Department of Pediatric, Kurdistan University of Medical Sciences, Sanandaj, Iran , magidmansoori@yahoo.com
2- Assistant Professor, Department of Obstetric & Gynecology,Kurdistan University of Medical Sciences, Sanandaj, Iran
3- Assistant Professor, Department of Pediatric, Kurdistan University of Medical Sciences, Sanandaj, Iran
4- Resident of Pediatric, Kurdistan University of Medical Sciences, Sanandaj, Iran
5- Midwifer, Kurdistan University of Medical Sciences, Sanandaj, Iran
Abstract:   (112159 Views)
Background and Objective: Respiratory distress syndrome is the most important lung problem during the neonatal period. Although the benefits of antenatal corticosteroids in neonates with a gestational age of less than 34 weeks have been demonstrated, the benefit of this treatment in neonates with higher gestational age is dubious. This study investigated the effect of Betamethasone on respiratory distress syndrome among neonates with gestational age of 35-36 weeks. Materials and Methods: This double blind randomized controlled trial study was done on 200 pregnant women who were of high risk for preterm labor in 35-36 weeks of gestation in Sanandaj city-Iran during 2007. 200 pregnant women randomly divided into treatment and placebo groups were received intramuscularly Betamethasone (12 mg/kg/BW twice) and normal saline, respectively. Data including age of mother, sex, weight, respiratory distress syndrome and newborns admission in hospital were recorded for each subject. Data was analyzed by using two-tailed T, Mann-Whitney, chi-square and Fisher exact tests. Results: There were no difference among two groups about age of mother, sex and weight of newborns. There were 8 (8%) and 20 (20%) newborns with respiratory distress syndrome in case and controls, respectively (P<0.01). Admission in hospital was 16% in Betamethasone group vs 28% in normal saline group (P<0.04). Conclusion: The study demonstrated that exposure to antenatal Betamethasone with 12mg/kg/BW twice between 35 and 36 weeks of gestation is associated with a significant reduction in the rate of respiratory distress syndrome.
Keywords: Corticosteroids, Respiratory distress syndrome, Preterm labor
Full-Text [PDF 308 kb] [English Abstract]   (16264 Downloads)    
Type of Study: Original Articles | Subject: Obstetrics and Gynecology
Send email to the article author


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Mansouri M (MD), Seyedolshohadaei F (MD), Company F (MD), Setare Sh (MD), Mazhari S (BSc). Effect of antenatal Betamethasone on prevention of respiratory distress syndrome among neonates with gestational age of 35-36 weeks. J Gorgan Univ Med Sci 2010; 12 (3) :18-23
URL: http://goums.ac.ir/journal/article-1-774-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 12, Issue 3 (10-2010) Back to browse issues page
مجله دانشگاه علوم پزشکی گرگان Journal of Gorgan University of Medical Sciences
Persian site map - English site map - Created in 0.05 seconds with 36 queries by YEKTAWEB 4660
Creative Commons License
This work is licensed under a Creative Commons — Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)